Sjaak Stevense
Corporate Officer/Principal en BioConnection BV .
Origen de la red de primer grado Sjaak Stevense.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Sandoz Pharmaceuticals Corp.
14
| Subsidiary | 14 | |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands.
4
| Holding Company | Biotechnology | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sjaak Stevense a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AMERICAN EXPRESS COMPANY | Finance/Rental/Leasing | Director/Board Member | |
PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
PEPSICO, INC. | Food: Specialty/Candy | Director/Board Member | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
BioTransplant, Inc.
BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Pharmaceuticals: Major | Director/Board Member | |
ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Extropy Pharmaceuticals, Inc. | Chief Executive Officer | ||
XBIOTECH INC. | Biotechnology | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Director/Board Member | |
NOVARTIS INDIA LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Chairman | |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Rutgers State University of New Jersey | College/University | Graduate Degree Undergraduate Degree | |
University of Guelph | College/University | Doctorate Degree | |
INSEAD | College/University | Director/Board Member | |
KBL Healthcare Ventures
KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare Ventures (KBL Healthcare) is a venture capital firm founded in 1991 by Zachary C. Berk and Marlene R. Krauss. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Chairman | |
University of Bern | College/University | Doctorate Degree | |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Carnegie Endowment for International Peace
Carnegie Endowment for International Peace Miscellaneous Commercial ServicesCommercial Services Carnegie Endowment for International Peace engages in the analysis and development of policy ideas and engagement and collaboration with decision makers in the government, business, and civil society. It refers to issues such as climate and energy, defense and security, democracy and governance, economy, foreign polocy, global governance, nuclear weapons, political reform, society and culture, and technology. The company was founded by Andrew Carnegie in 1910 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Biotechnology | Corporate Officer/Principal | |
XENO TRANSPLANTS CORPORATION | Biotechnology | Chairman | |
GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member | |
AVITA Medical Pty Ltd.
AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Chief Executive Officer | |
The Peres Center for Peace
The Peres Center for Peace Miscellaneous Commercial ServicesCommercial Services The Peres Center for Peace is a non-profit, non-political, non-governmental organization focused on developing and implementing cutting edge peacebuilding programs in innovation, peace education, medicine, business, and environment. It services include training to doctors, peace education, sports, culture and the arts and technology programs. The company was founded by Shimon Peres in 1996 and is headquartered in Tel Aviv-Jaffa, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
XBiotech USA, Inc.
XBiotech USA, Inc. BiotechnologyHealth Technology Part of XBiotech, Inc., XBiotech USA, Inc. is a company that manufactures antibodies. The company is based in Austin, TX. The company was founded in 2005. The CEO is John Simard. | Biotechnology | Director/Board Member | |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Private Equity Investor | |
Numab Therapeutics AG
Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard Business School | College/University | Graduate Degree | |
mPharma Health Nigeria Ltd.
mPharma Health Nigeria Ltd. Packaged SoftwareTechnology Services mPharma Health Nigeria Ltd. engages in the development of a pharmaceutical data management platform. The company was founded by Gregory Rockson, Dan Shoukimas and James Finucane in 2013 and is headquartered in Accra, Ghana. | Packaged Software | Director/Board Member | |
mPharma Data, Inc.
mPharma Data, Inc. Packaged SoftwareTechnology Services mPharma Data, Inc. engages in the development of an application that enables physicians to prescribe and locate medicines for patients. The company is headquartered in Lexington, MA. | Packaged Software | Director/Board Member | |
TOPADUR Pharma AG
TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Director/Board Member | |
Ontario Veterinary College | College/University | Doctorate Degree | |
SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED | Pharmaceuticals: Major | Director/Board Member | |
ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Gamida Cell, Inc.
Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Biotechnology | Director/Board Member | |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
AVITA MEDICAL, INC. | Medical Specialties | Chief Executive Officer | |
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology 7 Hills Pharma LLC is a clinical-stage pharmaceutical company based in Houston, TX. The private company is developing first-in-concept integrin activators to augment immunotherapies for the treatment of drug-resistant solid tumors and infectious diseases. The lead compound, 7HP349, is an oral VLA-4/LFA-1 allosteric activator that will be in phase I testing for PD-1 refractory solid tumors and geriatric influenza. The company's compounds are expected to augment antigen presentation and immune priming to facilitate a productive immune response against a variety of antigens. 7 Hills Pharma is managed by an experienced group of pharmaceutical executives, including Richard A. F. Dixon, Upendra K. Marathi, Kala Marathi, Peter Vanderslice, and Darren Woodside. Upendra K. Marathi has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Biotechnology | Chairman |
Estadísticas
Internacional
Estados Unidos | 34 |
Suiza | 7 |
Canadá | 4 |
Reino Unido | 3 |
India | 2 |
Sectorial
Health Technology | 28 |
Consumer Services | 7 |
Finance | 6 |
Commercial Services | 6 |
Technology Services | 5 |
Operativa
Director/Board Member | 92 |
Corporate Officer/Principal | 37 |
Chairman | 28 |
Chief Executive Officer | 24 |
President | 20 |
Las relaciones más conectadas
Insiders | |
---|---|
Philippe Chambon | 31 |
Michael Perry | 28 |
Daniel Vasella | 25 |
Timothy Rothwell | 24 |
Lawrence Olanoff | 22 |
Gilles Gagnon | 15 |
Derek Maetzold | 11 |
William McVicar | 11 |
Sijmen de Vries | 10 |
Alexandre F. Jetzer-Chung | 9 |
James T. O'Brien | 7 |
Ira Wallis | 7 |
Edward F. Heimers | 6 |
Victor A. Hartmann | 6 |
Robert J. Israel | 5 |
- Bolsa de valores
- Insiders
- Sjaak Stevense
- Conexiones Empresas